GSA Capital Partners’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-166,806
| Closed | -$215K | – | 1958 |
|
|
2021
Q4 | $215K | Sell |
166,806
-255,342
| -60% | -$329K | 0.03% | 1163 |
|
|
2021
Q3 | $916K | Buy |
422,148
+58,261
| +16% | +$126K | 0.09% | 348 |
|
|
2021
Q2 | $993K | Buy |
363,887
+216,919
| +148% | +$592K | 0.11% | 258 |
|
|
2021
Q1 | $384K | Sell |
146,968
-207,297
| -59% | -$542K | 0.06% | 496 |
|
|
2020
Q4 | $985K | Buy |
354,265
+233,340
| +193% | +$649K | 0.16% | 140 |
|
|
2020
Q3 | $559K | Buy |
120,925
+67,541
| +127% | +$312K | 0.09% | 325 |
|
|
2020
Q2 | $151K | Buy |
53,384
+12,347
| +30% | +$34.9K | 0.08% | 411 |
|
|
2020
Q1 | $100K | Buy |
41,037
+694
| +2% | +$1.69K | 0.03% | 897 |
|
|
2019
Q4 | $207K | Buy |
40,343
+27,482
| +214% | +$141K | 0.02% | 1239 |
|
|
2019
Q3 | $83K | Sell |
12,861
-12,700
| -50% | -$82K | 0.01% | 1291 |
|
|
2019
Q2 | $159K | Buy |
25,561
+799
| +3% | +$4.97K | 0.02% | 1281 |
|
|
2019
Q1 | $263K | Buy |
24,762
+5,163
| +26% | +$54.8K | 0.03% | 1072 |
|
|
2018
Q4 | $156K | Buy |
19,599
+3,650
| +23% | +$29.1K | 0.02% | 1157 |
|
|
2018
Q3 | $309K | Sell |
15,949
-2,750
| -15% | -$53.3K | 0.02% | 1308 |
|
|
2018
Q2 | $338K | Buy |
+18,699
| New | +$338K | 0.02% | 1337 |
|
|
2017
Q2 | – | Sell |
-4,538
| Closed | -$542K | – | 2026 |
|
|
2017
Q1 | $542K | Buy |
+4,538
| New | +$542K | 0.03% | 1052 |
|
|
2016
Q3 | – | Sell |
-1,250
| Closed | -$128K | – | 2032 |
|
|
2016
Q2 | $128K | Buy |
+1,250
| New | +$128K | 0.01% | 1652 |
|